Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis

嗜酸性粒细胞性食管炎早期环境危险因素的流行病学识别及机制研究

基本信息

  • 批准号:
    10214840
  • 负责人:
  • 金额:
    $ 69.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis ABSTRACT Eosinophilic esophagitis (EoE) is a recently recognized immune-mediated disease defined by abnormal infiltration of eosinophils into the esophageal mucosa, leading to failure to thrive, abdominal pain, vomiting, and heartburn in children, and progressing to esophageal stenosis and food impaction in adults. Though initially thought to be rare, the incidence and prevalence are rising dramatically, and over the past decade EoE has rapidly become a major cause of upper gastrointestinal morbidity. Despite increases in the understanding of the condition, it is currently not possible to determine why individual patients develop EoE. This is frustrating for patients and practitioners alike. EoE is considered to be an immune/allergen-mediated disease, and epidemiologic studies support a primarily environmental etiology. However, environmental risk factors have not been extensively studied in EoE, and prior studies, including by our own group, are limited by a crude assessment of exposures, recall bias, inability to assess fetal biomarkers, and lack of mechanistic understanding. Our goal is to address this knowledge gap by using an innovative method to precisely measure early life exposures in deciduous (primary, or “baby”) teeth that may be implicated in EoE development. Of particular interest are early life antibiotic exposure and duration and intensity of breastfeeding (which can be derived from barium levels in teeth). Increased antibiotic exposure and decreased breastfeeding have been linked to risk of atopic diseases. Measuring selected environmental exposures in teeth has never been applied to EoE, but we have documented the feasibility of this approach. This assessment, together with the use of novel cellular and molecular techniques for elucidating the mechanisms underlying the effects of these early life exposures, has the potential to greatly enhance our understanding of the pathogenesis of EoE. Our hypothesis is that the risk of EoE related to early life exposures is primarily due to an impaired esophageal epithelial barrier, and that genetic susceptibility will interact with the exposures to modify risk. The specific aims are to 1) determine the association between early life antibiotic exposure and EoE; 2) determine whether breastfeeding is associated with EoE, and evaluate whether the susceptibility genotype for CAPN14 modifies the association between breastfeeding and EoE; and 3) determine the functional significance and mechanisms of early life exposures on esophageal epithelial architecture and barrier function. To achieve these aims, we will conduct a case-control study to characterize temporal exposures, and in parallel will perform mechanistic analyses. This innovative, hypothesis-driven, and rigorously designed study will lead to robust and unbiased results. It will be conducted by a multidisciplinary team with recognized expertise in EoE, epidemiology, clinical/translational/lab research, and exposure science. The results will have a major impact on the understanding of EoE etiology and by potentially identifying opportunities for disease prevention which could lead to the development of new treatment options.
早期生活环境危险因素的流行病学鉴定和机制调查

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Evan Samuel Dellon其他文献

Evan Samuel Dellon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Evan Samuel Dellon', 18)}}的其他基金

An allergen-specific immune signature-directed diet vs sham diet for treatment of eosinophilic esophagitis: A pilot-feasibility study
过敏原特异性免疫特征导向饮食与假饮食治疗嗜酸性粒细胞性食管炎:一项试点可行性研究
  • 批准号:
    10413334
  • 财政年份:
    2022
  • 资助金额:
    $ 69.67万
  • 项目类别:
An allergen-specific immune signature-directed diet vs sham diet for treatment of eosinophilic esophagitis: A pilot-feasibility study
过敏原特异性免疫特征导向饮食与假饮食治疗嗜酸性粒细胞性食管炎:一项试点可行性研究
  • 批准号:
    10612916
  • 财政年份:
    2022
  • 资助金额:
    $ 69.67万
  • 项目类别:
Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis
嗜酸性粒细胞性食管炎早期环境危险因素的流行病学识别及机制研究
  • 批准号:
    10373071
  • 财政年份:
    2021
  • 资助金额:
    $ 69.67万
  • 项目类别:
Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis
嗜酸性粒细胞性食管炎早期环境危险因素的流行病学识别及机制研究
  • 批准号:
    10557169
  • 财政年份:
    2021
  • 资助金额:
    $ 69.67万
  • 项目类别:
Molecular and epigenetic predictors and mechanisms of treatment response to topical steroids in eosinophilic esophagitis
嗜酸粒细胞性食管炎局部类固醇治疗反应的分子和表观遗传预测因子及机制
  • 批准号:
    9975971
  • 财政年份:
    2020
  • 资助金额:
    $ 69.67万
  • 项目类别:
Budesonide versus fluticasone for treatment of eosinophilic esophagitis
布地奈德与氟替卡松治疗嗜酸性粒细胞性食管炎
  • 批准号:
    8856230
  • 财政年份:
    2014
  • 资助金额:
    $ 69.67万
  • 项目类别:
Budesonide versus fluticasone for treatment of eosinophilic esophagitis
布地奈德与氟替卡松治疗嗜酸性粒细胞性食管炎
  • 批准号:
    8670940
  • 财政年份:
    2014
  • 资助金额:
    $ 69.67万
  • 项目类别:
Risk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic Esophagitis
用于诊断的危险因素和生物标志物
  • 批准号:
    8186517
  • 财政年份:
    2011
  • 资助金额:
    $ 69.67万
  • 项目类别:
Risk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic Esophagitis
用于诊断的危险因素和生物标志物
  • 批准号:
    8331436
  • 财政年份:
    2011
  • 资助金额:
    $ 69.67万
  • 项目类别:
Risk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic Esophagitis
用于诊断的危险因素和生物标志物
  • 批准号:
    8521269
  • 财政年份:
    2011
  • 资助金额:
    $ 69.67万
  • 项目类别:

相似海外基金

Disrupted sleep architecture in adolescents with functional abdominal pain disorders
患有功能性腹痛疾病的青少年的睡眠结构被破坏
  • 批准号:
    10641146
  • 财政年份:
    2023
  • 资助金额:
    $ 69.67万
  • 项目类别:
Development and Testing of an Intervention to Facilitate Shared Decision-Making in Pediatric Patients with Abdominal Pain Presenting to the Community Emergency Department Setting
开发和测试一种干预措施,以促进社区急诊科就诊的腹痛儿科患者共同决策
  • 批准号:
    10723374
  • 财政年份:
    2023
  • 资助金额:
    $ 69.67万
  • 项目类别:
Abdominal Pain in Older Patients in Emergency Departments
急诊科老年患者的腹痛
  • 批准号:
    10739136
  • 财政年份:
    2023
  • 资助金额:
    $ 69.67万
  • 项目类别:
Evaluation of abdominal pain after mucosal healing in patients with inflammatory bowel disease -comprehensive analysis of HPA axis-
炎症性肠病患者黏膜愈合后腹痛评价-HPA轴综合分析-
  • 批准号:
    22K16013
  • 财政年份:
    2022
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain
针对有功能性腹痛风险的幼儿进行基于互联网的预防干预的随机对照试验
  • 批准号:
    10387725
  • 财政年份:
    2022
  • 资助金额:
    $ 69.67万
  • 项目类别:
Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain
针对有功能性腹痛风险的幼儿进行基于互联网的预防干预的随机对照试验
  • 批准号:
    10608073
  • 财政年份:
    2022
  • 资助金额:
    $ 69.67万
  • 项目类别:
Novel microbial driven histamine pathways underlying chronic abdominal pain
慢性腹痛背后的新型微生物驱动组胺途径
  • 批准号:
    453255
  • 财政年份:
    2021
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Operating Grants
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
  • 批准号:
    10619029
  • 财政年份:
    2020
  • 资助金额:
    $ 69.67万
  • 项目类别:
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
  • 批准号:
    10045379
  • 财政年份:
    2020
  • 资助金额:
    $ 69.67万
  • 项目类别:
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
  • 批准号:
    10685484
  • 财政年份:
    2020
  • 资助金额:
    $ 69.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了